Contract V797P5845X
Endo Pharmaceuticals Inc · Department Of Veterans Affairs · May 25, 2005
Endo Pharmaceuticals Inc was awarded a federal contract by Department Of Veterans Affairs on May 25, 2005 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 4 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on November 7, 2011. If all options are exercised, the contract could reach $315.00 million.
Contract details
- PIID
- V797P5845X
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- May 25, 2005
- Latest action
- November 7, 2011
Description
FSC GROUP 65, PART I, SECTION B - DRUGS, PHARMACEUTICALS&HEMATOLOGY RELATED PRODUCTS
Modification timeline
-
November 7, 2011Mod 38$0
-
May 10, 2011Mod 32$0
-
September 30, 2010Mod 28FSC GROUP 65, PART I, SECTION B - DRUGS, PHARMACEUTICALS & HEMATOLOGY RELATED PRODUCTS$0
-
May 24, 2010Mod 26FSC GROUP 65, PART I, SECTION B - DRUGS, PHARMACEUTICALS & HEMATOLOGY RELATED PRODUCTS$0
-
May 25, 2005Base awardPHARMACEUTICAL PRODUCTS$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract V797P5845X?
Contract V797P5845X is a federal contract awarded to Endo Pharmaceuticals Inc by Department Of Veterans Affairs on May 25, 2005 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 4 times since the base award.
Who won contract V797P5845X?
Endo Pharmaceuticals Inc won contract V797P5845X from Department Of Veterans Affairs.
How much is contract V797P5845X worth?
Contract V797P5845X has obligated $0 to date but carries a potential ceiling of $315.00 million if fully funded and all options are exercised.